[ET Net News Agency, 7 January 2026] REMEGEN (09995) rose 10% to HK$89.35.
It hits an intra-day high of HK$89.5, hitting an 1-month high, breaking above the 50-D SMA of HK$82.538, and an intra-day low of HK$80.5. The total shares traded was 5.62 million, with a value of HK$478.9m. The active buy/sell ratio is 70:30, with net buying turnover of HK$186.72m. CITIC SEC BRO accounts for greatest net responsive buying turnover of HK$918,025, with volume weighted average price of HK$87.431. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$43.85m, with volume weighted average price of HK$84.977. The stock has risen a combined 24.1% over the past 4 consecutive trading days.
Basic Information| Nominal | 89.350 | % Chg | +10.04% |
| High | 89.500 | Low | 80.500 |
| Shares Tr | 5.62m | Turnover | 478.9m |
| 10-D SMA | 77.375 | %H.V | 60.366 |
| 20-D SMA | 77.335 | VWAP | 85.176 |
| 50-D SMA | 82.538 | RSI14 | 63.234 |
Status: Breaking above the 50-D SMA, hitting an 1-month high, active buy/sell ratio is 70:30, with net buying turnover of HK$186.72m, rising a combined 24.1% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| REMEGEN (09995) | 89.35 | +10.04 |
| SINO BIOPHARM (01177) | 6.67 | +1.37 |
| HENGRUI PHARMA (01276) | 76.35 | +2.41 |
| 3SBIO (01530) | 27.34 | +4.11 |
| KEYMED BIO-B (02162) | 58.10 | +2.29 |
| WUXI XDC (02268) | 66.90 | +2.69 |
| ASCENTAGE-B (06855) | 54.80 | +6.41 |
| SKB BIO-B (06990) | 460.00 | +4.31 |
| DUALITYBIO-B (09606) | 345.20 | +1.59 |
| AKESO (09926) | 127.10 | +5.56 |
(ed)
